Next Generation Sequencing Market Is Driven By Rising Development Of Efficient And Rapid Genomic Sequencing Till 2025: Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.rn”
The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025, according to report by Grand View Research, Inc. Increasing coverage of NGS is expected to drive use of precision medicine in oncology from research based setting to clinical cancer setting.

According to a report published by Grand View Research, Inc.; the global next generation sequencing (NGS) market is anticipated to accomplish a valuation of around USD 21.4 billion by 2025. Development of efficient and rapid genomic sequencing can drive the market during the forecast period (2013 to 2024). In addition, ongoing R&D projects in proteomics, metabolomics, and transcriptomics are anticipated to boost the adoption of the technology in the coming years. Since, Genomics and proteomics involve collection of large amounts of information to be collected and sorted for sequence determination. Implementation of automation in pre-sequencing protocols is also expected to support the market growth.

Development of personalized medicines at a genetic level is likely to augment demand for NGS during the forecast period. Drug developers and scientists are focusing more on utilization of this technology to develop personalized medicines. The technology is also expected to be utilized in oncology and several infectious disease diagnoses. This is also expected to bode well for the market. Additionally, growing implementation of NGS-based smaller scale platforms for clinical diagnostics can have positive impact on the market.

Full Research Report On Next Generation Sequencing (NGS) Market Analysis:

UK NGS market revenue, by technology, 2013 – 2024 (USD Million)

UK NGS market revenue, by technology, 2013 - 2024 (USD Million)

Furthermore, introduction of products that offers complete workflow such as sampling to report generation post data interpretation is also expected to support the market growth. Additionally, availability of better commercial models like price-per-insight options involve low primary investment and labs better cost management will also increase the demand in the coming years.

Worldwide next generation sequencing (NGS) market can be segmented on the basis of application, technology, work-flow, end-use, and region. Based on application, the market can be split into reproductive health, oncology, agrigenomics and forensics, clinical investigation, consumer genomics, HLA typing/immune system monitoring, and metagenomics, epidemiology and drug development. The oncology segment is projected to display remunerative growth in the years to come. This growth can be attributed to improvement in sequencing that can offer targeted sequence determination of cancer genes. This allows oncologists to genetic information about cancer cells and tumors. As per, technology, the market can be bifurcated into targeted sequencing analysis, whole genome sequencing (WGS), and whole exome sequencing. The targeted resequencing analysis segment conquered the market due to its associated benefits with smaller data set and implementation as lower turnaround time. On other hand, the WGS segment is projected to display fastest growth in the coming years. This can be attributed to rising research programs with an aim to map human and non-human whole genomes. Based on work-flow, the market can be classified into pre-sequencing and sequencing. The sequencing segment accounted for the largest share in terms of revenue in 2015. The data analysis is anticipated to show notable growth due to rise in efforts towards the development of novel algorithms. As per end-use, the market can be categorized into academic research, clinical research, hospitals and clinics, pharma and biotech entities, and other users. The academic research segment occupies the largest share in terms of revenue and expected to continue its dominance in the coming years. This can be attributed to presence of numerous R&D projects and availability of on-site bioinformatics courses, which include study regarding implementation of NGS and data analysis.

Browse More Reports Of This Category By Grand View Research At:

Global next generation sequencing market by applications, 2015 & 2025 (USD Million)

Global next generation sequencing market by applications, 2015 & 2025 (USD Million)

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Large number of universities, which provides courses related to molecular biology are situated in Germany, the U.K., and the U.S. This is responsible for growth of this industry in Europe and North America. North America occupied the largest portion of the market in 2015. This can be credited to existence of technologically advanced healthcare infrastructure, increasing R&D expenses for determination of proteomic and genomic sequence for biomarkers research, and reduction in the cost of sequencing per base pair. Asia Pacific is anticipated to expand rapidly with a CAGR of over 18% during the forecast period. This growth can be ascribed to rising expenditure for healthcare, increasing awareness level among the individuals, and improving economic condition.

Some of the leading companies operating in the next generation sequencing (NGS) market include Illumina Inc.; Oxford Nanopore Technologies Inc.; DNAStar Inc.; Agilent Technologies Inc.; and Macrogen Inc.

Grand View Research has segmented the NGS market on the basis of application, technology, workflow, and end use:

NGS Outlook, by Application (Revenue, USD Million; 2014 – 2025)

  • Reproductive Health

    • NIPT

    • PGT

    • Newborn/Genetic Screening

  • Oncology

  • HLA Typing/Immune System Monitoring

  • Metagenomics, Epidemiology & Drug Development

  • Agrigenomics & Forensics

  • Consumer Genomics

  • Clinical Investigation

    • Idiopathic Diseases

    • Inherited Diseases

    • Infectious Diseases

    • Non-Communicable / Other Diseases

NGS Outlook, by Technology (Revenue, USD Million; 2014 – 2025)

  • Targeted Sequencing Analysis

    • DNA Based Targeted Sequencing Analysis

    • RNA Based Targeted Sequencing Analysis

  • Whole Genome Sequencing

  • Whole Exome Sequencing 

NGS Outlook, by Workflow (Revenue, USD Million; 2014 – 2025)

  • Pre-sequencing

    • NGS Library Preparation Kits

    • NGS Semi-automated Library Preparation

    • NGS Automated Library Preparation

    • Clonal Amplification

  • Sequencing

    • Data Analysis

      • Primary Data Analysis

      • Secondary Data Analysis

      • Tertiary Data Analysis

NGS Outlook, by End-use (Revenue, USD Million; 2014 – 2025)

  • Academic Research

  • Clinical Research

  • Hospitals & Clinics

  • Pharma & Biotech Entities

  • Other Users

NGS Outlook, by Region (Revenue, USD Million; 2014 – 2025)

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Explore the BI enabled intuitive market research database, Navigate with Grand View Compass, by Grand View Research, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information:

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
State: California
Country: United States